Skip to main content
ECS BOTANICS HOLDINGS LTD logo

ECS BOTANICS HOLDINGS LTD — Investor Relations & Filings

Ticker · ECS ISIN · AU0000052490 LEI · 254900F6I1ORKXFIGD77 ASX Agriculture, forestry and fishing
Open in API
Filings indexed 913 across all filing types
Latest filing 2021-09-19 Board/Management Inform…
Country AU Australia
Listing ASX ECS

About ECS BOTANICS HOLDINGS LTD

https://ecs-botanics.com/

ECS Botanics Holdings Ltd specializes in the large-scale cultivation and manufacture of medicinal cannabis products. The company utilizes organic and sustainable farming practices, including regenerative agriculture, to produce high-quality cannabis flower and oils. Its operations integrate advanced greenhouse technology with outdoor cultivation to ensure cost-effective production. The product portfolio includes a range of pharmaceutical-grade dried flowers and extracted oils tailored for medical applications. Serving both domestic and international markets, the company focuses on supplying GMP-compliant products to healthcare providers and pharmaceutical distributors. By leveraging low-cost production models and environmentally conscious methodologies, the organization maintains a competitive position in the global medicinal supply chain.

Recent filings

Filing Released Lang Actions
World class advisory board established 2 pages 129.6KB
Board/Management Information Classification · 95% confidence The document is an ASX announcement dated 20 September 2021 from ECS Botanics Holdings Ltd. It announces the establishment of an advisory board with six industry leaders to support the company's growth in the medicinal cannabis business. The content focuses on appointments and the strategic role of the advisory board, with no financial data, regulatory filings, or report attachments. The document is relatively short (3976 characters) and is an announcement of a board-related development rather than a full report or financial disclosure. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or additions to the company's board or senior management.
2021-09-19 English
Notice of Annual General Meeting/Proxy Form 22 pages 808.8KB
AGM Information Classification · 95% confidence The document is a Notice of Annual General Meeting (AGM) and Explanatory Memorandum for ECS Botanics Holdings Ltd, dated 20 September 2021, for an AGM scheduled on 22 October 2021. It includes details about the meeting agenda, resolutions to be voted on, proxy voting instructions, and references to the Annual Report being available online. The content is focused on informing shareholders about the AGM, the meeting logistics, and the voting process, rather than presenting financial results or detailed reports. The document length is about 15,000 characters, which is consistent with a detailed AGM notice and explanatory materials. There is no actual financial data or earnings information presented, so it is not an Annual Report or Earnings Release. It is not a voting results announcement, nor a management or governance report. Therefore, the document fits the category of AGM Information (AGM-R).
2021-09-19 English
Change of Director's Interest Notice (x2) 5 pages 222.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and contains detailed disclosures about changes in securities holdings by company directors, including the number of shares and options acquired or disposed, dates of changes, and nature of interests. It references ASX listing rules and the Corporations Act, which are typical for insider trading or director dealings disclosures. The content is focused on personal share transactions by company directors, not on financial results, management changes, or other corporate filings. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length and detail confirm it is the actual notice, not just an announcement or certification. Therefore, the correct classification is DIRS.
2021-09-09 English
ECS secures supply agreement with Canngea 2 pages 303.4KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 8 September 2021 from ECS Botanics Holdings Ltd. It details a new supply agreement with an Australian cannabis company, Canngea, including contract terms and expected revenue. The content focuses on a business update regarding a commercial contract rather than financial results, regulatory filings, or management changes. The document length is 4329 characters, which is relatively short and typical for an announcement. There is no indication of financial statements, audit information, or detailed management discussion. The nature of the content fits best with a Capital/Financing Update (CAP) as it relates to a material commercial agreement expected to impact revenue and business operations. Therefore, the appropriate classification is CAP with high confidence.
2021-09-07 English
Application for quotation of securities - ECS 7 pages 30.6KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options and performance rights into ordinary fully paid shares. It includes specifics about the number of securities, issue dates, and the nature of the securities being quoted. This is a capital market activity related to the issuance and quotation of new shares rather than a financial report, management discussion, or regulatory filing. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not merely an announcement of a report but a detailed filing about securities issuance and quotation.
2021-09-07 English
Secondary Trading Notice 2 pages 294.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement titled 'SECONDARY TRADING NOTICE' related to the issuance of shares pursuant to the vesting of performance rights. It references compliance with sections of the Corporations Act 2001 and provides a legal notice about the exemption for on-sale of securities. The document is short (2494 characters) and does not contain financial statements or detailed financial data. It is a regulatory announcement about share issuance and trading status rather than a full financial report or earnings release. Therefore, it fits best under 'Regulatory Filings' (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-09-07 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.